Casein kinase II interacts with prion protein in vitro and forms complex with native prion protein in vivo

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 12, 2008, Pages 1039-1047

  Chen, Jianming ^a   Gao, Chen ^a   Shi, Qi ^a   Wang, Guirong ^a   Lei, Yanjun ^a   Shan, Bing ^a   Zhang, Baoyun ^a   Dong, Chenfang ^a   Shi, Song ^a   Wang, Xin ^a   Tian, Chan ^a   Han, Jun ^a   Dong, Xiaoping ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Casein kinase II (CK2); Kinase; Prion disease; Prion protein (PrP); Protein interaction; Transmissible spongiform encephalopathy (TSE)

Indexed keywords

CASEIN KINASE II; PRIMER DNA; RECOMBINANT PROTEIN;

ARTICLE; CELL LINE; HUMAN; IMMUNOPRECIPITATION; METABOLISM; NUCLEOTIDE SEQUENCE; PRION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CASEIN KINASE II; CELL LINE; DNA PRIMERS; HUMANS; IMMUNOPRECIPITATION; PRIONS; PROTEIN BINDING; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

CRICETINAE; ESCHERICHIA COLI;

EID: 57849157424     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00486.x     Document Type: Article

References (40)

1. Prusiner SB., Prions. Proc Natl Acad Sci USA 1998, 95 : 13363 13383
2. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE., Prion protein biology. Cell 1998, 93 : 337 348
3. Johnson RT., Prion diseases. Lancet Neurol 2005, 4 : 635 642
4. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R., Cellular prion protein transduces neuroprotective signals. EMBO J 2002, 21 : 3317 3326
5. Lasmezas CI., Putative functions of PrP(C). Br Med Bull 2003, 66 : 61 70
6. Millhauser GL., Copper and the prion protein: methods, structures, function, and disease. Annu Rev Phys Chem 2007, 58 : 299 320
7. Westergard L, Christensen HM, Harris DA., The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007, 1772 : 629 644
8. Azzalin A, Ferrara V, Arias A, Cerri S, Avella D, Pisu MB, Nano R et al., Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. Biochem Biophys Res Commun 2006, 346 : 108 115
9. Gao C, Lei YJ, Han J, Shi Q, Chen L, Guo Y, Gao YJ et al., Recombinant neural protein PrP can bind with both recombinant and native apolipoprotein E in vitro. Acta Biochim Biophys Sin 2006, 38 : 593 601
10. Han J, Zhang J, Yao HL, Wang XF, Li F, Chen L, Gao C et al., Study on interaction between microtubule associated protein tau and prion protein. Sci China C Life Sci 2006, 49 : 473 479
11. Nieznanski K, Nieznanska H, Skowronek KJ Osiecka KM, Stepkowski D., Direct interaction between prion protein and tubulin. Biochem Biophys Res Commun 2005, 334 : 403 411
12. C directly interacts with proteins involved in signaling pathways. J Biol Chem 2001, 276 : 44604 44612
13. Ahmed K, Gerber DA, Cochet C., Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 2002, 12 : 226 230
14. Guerra B, Boldyreff B, Sarno S, Cesaro L, Issinger OG, Pinna LA., CK2: a protein kinase in need of control. Pharmacol Ther 1999, 82 : 303 313
15. Litchfield DW., Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 2003, 369 : 1 15
16. Pinna LA., Protein kinase CK2: a challenge to canons. J Cell Sci 2002, 115 : 3873 3878
17. Blanquet PR., Neurotrophin-induced activation of casein kinase 2 in rat hippocampal slices. Neuroscience 1998, 86 : 739 749
18. Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I., CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem 2005, 274 : 63 67
19. Lim AC, Hou Z, Goh CP, Qi RZ., Protein kinase CK2 is an inhibitor of the neuronal Cdk5 kinase. J Biol Chem 2004, 279 : 46668 46673
20. Meggio F, Pinna LA., One-thousand-and-one substrates of protein kinase CK2? FASEB J 2003, 17 : 349 368
21. Aksenova MV, Burbaeva GS, Kandror KV Kapkov DV, Stepanov AS., The decreased level of casein kinase 2 in brain cortex of schizophrenic and Alzheimer's disease patients. FEBS Lett 1991, 279 : 55 57
22. Iimoto DS, Masliah E, DeTeresa R, Terry RD, Saitoh T., Aberrant casein kinase II in Alzheimer's disease. Brain Res 1990, 507 : 273 280
23. Chen JM, Gao C, Shi Q Shan B, Lei YJ, Dong CF, An R et al., Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies. Arch Virol 2008, 153 : 1013 1020
24. Gao JM, Gao C, Han J, Zhou XB, Xiao XL, Zhang J, Chen L et al., Dynamic analyses of PrP and PrP(Sc) in brain tissues of golden hamsters infected with scrapie strain 263K revealed various PrP forms. Biomed Environ Sci 2004, 17 : 8 20
25. Negro A, Meggio F, Bertoli A, Battistutta R, Sorgato MC, Pinna LA., Su sceptibility of the prion protein to enzymic phosphorylation. Biochem Biophys Res Commun 2000, 271 : 337 341
26. Meggio F, Negro A, Sarno S, Ruzzene M, Bertoli A, Sorgato MC, Pinna LA., Bovine prion protein as a modulator of protein kinase CK2. Biochem J 2000, 352 : 191 196
27. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL et al., Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001, 314 : 1209 1225
28. Dong CF, Shi S, Wang XF, An R, Li P, Chen JM, Wang X et al., The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch Biochem Biophys 2008, 470 : 83 92
29. Dong CF, Wang XF, Wang X, Shi S, Wang GR, Shan B, An R et al., Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro. Med Microbiol Immunol 2008, 197 : 361 368
30. Lu X, Wintrode PL, Surewicz WK., Beta-sheet core of humanprion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci USA 2007, 104 : 1510 1515
31. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K., NMR structure of the mouse prion protein domain PrP(121-321). Nature 1996, 382 : 180 182
32. Zahn R, Liu A, Lührs T, Riek R, von Schroetter C, López García F, Billeter M et al., NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 2000, 97 : 145 150
33. Martel V, Filhol O, Nueda A, Cochet C., Dynamic localization/association of protein kinase CK2 subunits in living cells: a role in its cellular regulation? Ann NY Acad Sci 2002, 973 : 272 277
34. Rodriguez FA, Contreras C, Bolanos-Garcia V, Allende JE., Protein kinase CK2 as an ectokinase: the role of the regulatory CK2beta subunit. Proc Natl Acad Sci USA 2008, 105 : 5693 5698
35. Hugel B, Martínez MC, Kunzelmann C, Blättler T, Aguzzi A, Freyssinet JM., Modulation of signal transduction through the cellular prion protein is linked to its incorporation in lipid rafts. Cell Mol Life Sci 2004, 61 : 2998 3007
36. Taylor DR, Hooper NM., The prion protein and lipid rafts. Mol Membr Biol 2006, 23 : 89 99
37. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ et al., A transmembrane form of the prion protein in neurodegenerative disease. Science 1998, 279 : 827 834
38. Mironov A Jr., Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D et al., Cytosolic prion protein in neurons. J Neurosci 2003, 23 : 7183 7193
39. Safar J, Prusiner SB., Molecular studies of prion diseases. Prog Brain Res 1998, 117 : 421 434
40. Chen L, Yang Y, Han J, Zhang BY, Zhao L, Nie K, Wang XF et al., Removal of the glycosylation of prion protein provokes apoptosis in SF126. J Biochem Mol Biol 2007, 40 : 662 669